A subsidiária da China Medical System assinou um Acordo de Novação. China Medical System's subsidiary signed a Novation Agreement.

A China Medical System (00867) anunciou em 3 de fevereiro de 2024 que sua subsidiária integral celebrou um acordo de novação com a Vifor Fresenius Medical Care Renal Pharma Ltd. e a Winhealth Investment para os comprimidos mastigáveis ​​de oxihidróxido sucroférrico Velphoro®. China Medical System (00867) announced on February 3, 2024, that its wholly-owned subsidiary entered into a Novation Agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. and Winhealth Investment for the sucroferric oxyhydroxide chewable tablets Velphoro®. O Contrato de Licença entre a Winhealth Investment e a VFMCRP foi assinado em 28 de junho de 2023, concedendo à Winhealth Investment uma licença exclusiva para registar, importar, promover, distribuir, utilizar e vender o produto na China Continental, Hong Kong, Macau e Taiwan. The License Agreement between Winhealth Investment and VFMCRP was signed on June 28, 2023, granting Winhealth Investment an exclusive license to register, import, promote, distribute, use, and sell the product in Mainland China, Hong Kong, Macao, and Taiwan.